Most sold healthcare stocks in Q2 2019
See which Healthcare stocks institutional investors trimmed or exited the most in Q2 2019, measured as net reductions in reported share positions from Q1 2019 into Q2 2019. Notable reductions at the top of this list include MODERNA INC (MRNA), NOVARTIS AG-SPONSORED ADR (NVS), BAXTER INTERNATIONAL INC (BAX), ELI LILLY & CO (LLY). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| MRNA | MODERNA INC | -8,188,608 | -$215.05M | 1 | 0 | 1 | 0 | 2 |
| NVS | NOVARTIS AG-SPONSORED ADR | -6,218,697 | -$763.44M | 0 | 4 | 4 | 1 | 9 |
| BAX | BAXTER INTERNATIONAL INC | -5,083,096 | -$399.30M | 0 | 0 | 4 | 1 | 5 |
| LLY | ELI LILLY & CO | -4,351,107 | -$790.02M | 0 | 1 | 4 | 1 | 5 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | -2,345,800 | -$218.96M | 0 | 1 | 2 | 1 | 3 |
| MD | PEDIATRIX MEDICAL GROUP INC | -2,238,641 | -$62.29M | 0 | 1 | 0 | 1 | 1 |
| CVS | CVS HEALTH CORP | -2,027,840 | -$87.53M | 1 | 4 | 4 | 1 | 10 |
| ABT | ABBOTT LABORATORIES | -1,232,933 | -$83.60M | 0 | 1 | 3 | 1 | 8 |
| EHC | ENCOMPASS HEALTH CORP | -1,181,546 | -$63.41M | 0 | 1 | 1 | 1 | 2 |
| TMO | THERMO FISHER SCIENTIFIC INC | -1,051,057 | -$232.81M | 2 | 2 | 7 | 2 | 14 |
| PDCO | PATTERSON COS INC | -1,048,069 | -$21.95M | 0 | 1 | 1 | 1 | 2 |
| A | AGILENT TECHNOLOGIES INC | -1,021,094 | -$116.29M | 0 | 1 | 1 | 2 | 3 |
| DXCM | DEXCOM INC | -967,356 | -$105.96M | 0 | 0 | 1 | 1 | 1 |
| KPTI | KARYOPHARM THERAPEUTICS INC | -845,285 | -$4.93M | 0 | 0 | 1 | 0 | 1 |
| EXAS | EXACT SCIENCES CORP | -688,990 | $23.78M | 0 | 1 | 1 | 1 | 2 |
| NTRA | NATERA INC | -674,200 | -$13.22M | 0 | 0 | 1 | 0 | 1 |
| PFE | PFIZER INC | -664,018 | -$10.08M | 0 | 6 | 7 | 1 | 13 |
| EBS | EMERGENT BIOSOLUTIONS INC | -628,158 | -$34.72M | 0 | 0 | 1 | 1 | 1 |
| MRK | MERCK & CO. INC. | -607,561 | -$44.88M | 1 | 5 | 7 | 1 | 16 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -601,134 | $18.82M | 0 | 0 | 2 | 1 | 2 |
| STAA | STAAR SURGICAL CO | -566,894 | -$20.30M | 0 | 0 | 1 | 1 | 1 |
| PTCT | PTC THERAPEUTICS INC | -538,240 | -$17.54M | 0 | 0 | 1 | 0 | 1 |
| XRAY | DENTSPLY SIRONA INC | -520,395 | -$11.61M | 1 | 0 | 2 | 1 | 5 |
| RGNX | REGENXBIO INC | -519,300 | -$31.84M | 0 | 0 | 1 | 0 | 1 |
| MCK | MCKESSON CORP | -477,246 | $127.08M | 0 | 1 | 4 | 0 | 6 |
| HCA | HCA HEALTHCARE INC | -445,012 | -$56.06M | 0 | 0 | 1 | 1 | 2 |
| MGNX | MACROGENICS INC | -399,300 | -$7.61M | 0 | 0 | 1 | 0 | 1 |
| OMI | OWENS & MINOR INC | -375,912 | -$2.29M | 0 | 1 | 0 | 1 | 1 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | -368,705 | -$14.22M | 1 | 0 | 1 | 0 | 2 |
| VCEL | VERICEL CORP | -361,092 | -$6.32M | 0 | 0 | 0 | 1 | 0 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | -357,453 | -$4.84M | 0 | 0 | 0 | 1 | 0 |
| VCYT | VERACYTE INC | -351,720 | $3.63M | 0 | 1 | 1 | 0 | 2 |
| AMGN | AMGEN INC | -344,815 | -$89.70M | 0 | 3 | 3 | 2 | 7 |
| UNH | UNITEDHEALTH GROUP INC | -341,577 | -$156.44M | 0 | 9 | 6 | 2 | 15 |
| ALGN | ALIGN TECHNOLOGY INC | -320,753 | -$169.13M | 0 | 2 | 5 | 1 | 8 |
| AMRX | AMNEAL PHARMACEUTICALS INC | -315,700 | -$4.97M | 0 | 0 | 1 | 0 | 1 |
| MNKD | MANNKIND CORP | -305,954 | -$603.00K | 0 | 0 | 0 | 1 | 0 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | -297,831 | -$40.13M | 1 | 1 | 1 | 0 | 3 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | -297,400 | -$1.42M | 0 | 0 | 1 | 0 | 1 |
| SGMO | SANGAMO THERAPEUTICS INC | -297,264 | -$2.06M | 0 | 0 | 1 | 1 | 1 |
| HALO | HALOZYME THERAPEUTICS INC | -296,384 | -$4.20M | 0 | 0 | 2 | 0 | 4 |
| DHR | DANAHER CORP | -293,578 | $124.32M | 0 | 1 | 5 | 1 | 9 |
| ARAY | ACCURAY INC | -274,723 | -$5.90M | 0 | 0 | 1 | 0 | 1 |
| CRL | CHARLES RIVER LABORATORIES | -266,021 | -$46.95M | 0 | 0 | 2 | 1 | 2 |
| MTNB | MATINAS BIOPHARMA HOLDINGS I | -253,000 | -$276.00K | 0 | 0 | 0 | 1 | 0 |
| AMED | AMEDISYS INC | -229,341 | -$28.28M | 0 | 0 | 1 | 1 | 1 |
| NBIX | NEUROCRINE BIOSCIENCES INC | -223,200 | -$19.72M | 0 | 0 | 1 | 1 | 1 |
| RDNT | RADNET INC | -203,300 | -$217.00K | 0 | 0 | 1 | 0 | 1 |
| EVH | EVOLENT HEALTH INC - A | -195,499 | -$2.46M | 0 | 0 | 0 | 1 | 0 |
| IDXX | IDEXX LABORATORIES INC | -193,328 | $234.51M | 0 | 2 | 1 | 0 | 5 |
Frequently asked questions about Most sold healthcare stocks in Q2 2019
What are the most sold Healthcare stocks in Q2 2019?
The most sold healthcare stocks in Q2 2019 are those with the largest decrease in reported share counts across institutional investors compared to Q1 2019, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q2 2019?
Among filers in this sector, net reductions were largest in companies such as MODERNA INC (MRNA), NOVARTIS AG-SPONSORED ADR (NVS), BAXTER INTERNATIONAL INC (BAX), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2019).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.